Valentina Lorenzetti
Overview
Explore the profile of Valentina Lorenzetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
2272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ganesan S, Van Dam N, Kamboj S, Tsuchiyagaito A, Sacchet M, Misaki M, et al.
bioRxiv
. 2024 Nov;
PMID: 39484554
Meditation can benefit well-being and mental health, but novices often struggle to effectively recognize and disengage from mental processes during meditation due to limited awareness, potentially diminishing meditation's benefits. We...
2.
Murphy E, Poudel G, Ganesan S, Suo C, Manning V, Beyer E, et al.
Neurosci Biobehav Rev
. 2024 Aug;
165:105865.
PMID: 39197715
Introduction: Real-time functional magnetic resonance based-neurofeedback (fMRI-neurofeedback) is a neuromodulation tool where individuals self-modulate brain function based on real-time feedback of their brain activity. fMRI-neurofeedback has been used to target...
3.
Verdejo-Garcia A, Berry J, Caracuel A, Copersino M, Field M, Garland E, et al.
World Psychiatry
. 2024 May;
23(2):299-301.
PMID: 38727073
No abstract available.
4.
Labuschagne I, Dominguez J, Grace S, Mizzi S, Henry J, Peters C, et al.
Hum Brain Mapp
. 2024 Apr;
45(5):e26673.
PMID: 38590248
The amygdala is important for human fear processing. However, recent research has failed to reveal specificity, with evidence that the amygdala also responds to other emotions. A more nuanced understanding...
5.
Lorenzetti V, Gaillard A, McTavish E, Grace S, Rossetti M, Batalla A, et al.
Cannabis Cannabinoid Res
. 2024 Mar;
9(6):e1565-e1578.
PMID: 38498015
Males and females who consume cannabis can experience different mental health and cognitive problems. Neuroscientific theories of addiction postulate that dependence is underscored by neuroadaptations, but do not account for...
6.
Dawson D, Stjepanovic D, Lorenzetti V, Cheung C, Hall W, Leung J
Drug Alcohol Depend
. 2024 Mar;
257:111263.
PMID: 38493566
Background: The prevalence of cannabis use disorders (CUDs) in people who use cannabis recreationally has been estimated at 22%, yet there is a dearth of literature exploring CUDs among people...
7.
Bhardwaj A, Mills L, Doyle M, Sahid A, Montebello M, Monds L, et al.
BMC Psychiatry
. 2024 Mar;
24(1):175.
PMID: 38433233
Background: Cannabis use disorder (CUD) is increasingly common and contributes to a range of health and social problems. Cannabidiol (CBD) is a non-intoxicating cannabinoid recognised for its anticonvulsant, anxiolytic and...
8.
Beyer E, Poudel G, Antonopoulos S, Thomson H, Lorenzetti V
Front Behav Neurosci
. 2024 Feb;
17:1323609.
PMID: 38379938
Rationale: Cannabis is one of the most widely used psychoactive substances globally. Cannabis use can be associated with alterations of reward processing, including affective flattening, apathy, anhedonia, and lower sensitivity...
9.
Poudel G, Sharma P, Lorenzetti V, Parsons N, Cerin E
Neuroinformatics
. 2024 Feb;
22(2):107-118.
PMID: 38332409
Visibility graphs provide a novel approach for analysing time-series data. Graph theoretical analysis of visibility graphs can provide new features for data mining applications in fMRI. However, visibility graphs features...
10.
Cao Z, McCabe M, Callas P, Cupertino R, Ottino-Gonzalez J, Murphy A, et al.
Front Neuroimaging
. 2024 Jan;
2:1138193.
PMID: 38179200
Introduction: There are growing concerns about commonly inflated effect sizes in small neuroimaging studies, yet no study has addressed recalibrating effect size estimates for small samples. To tackle this issue,...